-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Better Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2023.
- Better Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$5.34M, a 51.4% increase year-over-year.
- Better Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$29.6M, a 29.6% increase year-over-year.
- Better Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$38.3M, a 25.2% decline from 2021.
- Better Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.6M, a 383% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)